ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 143095 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 143095; 2) Community: the network communities that were significantly associated with the response to NSC 143095; 3) Molecule: the relationships between components within communities and NSC 143095; 4) MDR: the compounds that were significantly associated with the NSC 143095.

NSC Compound Enrichment Correlation
NSC 129794 Ethanesulfonic acid, compd. with 2-chloro-5-[4-[m-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)phenyl]butyl]benzenesulfonyl fluoride (1:1) 0.0396077140933377 0.23078956
NSC 717705 Null 0.0396077140933379 -0.079573305
NSC 148790 Card-20(22)-enolide, 16-(acetyloxy)-3,14-dihydroxy-, (3.beta.,5.beta.,16.beta.)- (9CI) 0.039607714093338 0.35394474
NSC 173552 L-Aspartic acid, N-[4-[[(2-amino-4-hydroxy-6-quinazolinyl)methyl]amino]benzoyl]-, monohydrate 0.039607714093338 0.74004325
NSC 267713 Digitoxigenin glycoside 0.039607714093338 0.3118742
NSC 32951 Acetic acid, (2,4-dihydroxy-2H-pyran-3(6H)-ylidene)-, 3,4-lactone 0.039607714093338 0.062317573
NSC 339579 7H-Pyrrolo[3,2-f]quinazoline-2,4-diamine, 7-[(3-nitrophenyl)methyl]-, monoacetate 0.039607714093338 0.69601954
NSC 372155 2-Propenamide, N-[(cyanoamino)iminomethyl]-2-methyl- 0.039607714093338 0.069684276
NSC 52426 Null 0.039607714093338 0.46889397
NSC 624657 ANTINEOPLASTIC-624657 0.039607714093338 0.22168168
Total:97  Current:83    [First] [Prev] [Next] [Last]